FTC Clears Cephalon's $225M Gemin X Buyout

By Samuel Howard · April 5, 2011, 3:53 PM EDT

The Federal Trade Commission on Tuesday gave Cephalon Inc. the go-ahead for its $225 million acquisition of Gemin X Pharmaceuticals Inc., a privately held biopharmaceutical company developing cutting-edge cancer therapeutics....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Samuel

February 08, 2012
PE's Healing Touch Faces Test In Hospital Buys
January 25, 2012
Planned Parenthood Buys NY Headquarters For $35M
January 05, 2012
Schein Buys Oak Hill's Stake In Vet Supply Unit For $155M
November 21, 2011
PE Firm Ratos Sells 2 Cos. To 3D Systems For $137M
November 21, 2011
Valeant Buys INova From PE Firms For $688M
November 08, 2011
Goodwin Helps TA Snag Senior Whole Health For $135M
November 01, 2011
Hogan Lovells Guides Glucose Tester In $54M Fundraising
October 20, 2011
VC Firm Pursues Massive $250M Hospital Project In Texas
October 13, 2011
Centurion Shores Up Biotech Outfit With $10M Investment
October 07, 2011
Simpson, Kirkland Aid Investors In $1.6B KCI Notes Deal